Polymorphisms in the catechol‐O‐methyltransferase (COMT) gene influence plasma total homocysteine levels
- 22 August 2008
- journal article
- research article
- Published by Wiley in American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics
- Vol. 147B (6) , 996-999
- https://doi.org/10.1002/ajmg.b.30700
Abstract
Elevated plasma total homocysteine (tHcy) is a risk factor for various disorders. We investigated whether functional polymorphisms in catechol‐O‐methyltransferase (COMT) influence tHcy, since COMT activity producesS‐adenosylhomocysteine (SAH), a homocysteine precursor. We hypothesized that high activity COMT variants would be associated with high tHcy, since they presumably result in increased formation of SAH. We genotyped 780 community‐dwelling elderly individuals for functionalCOMT(Val158Met and A−287G) and methylenetetrahydrofolate reductase (MTHFR; C677T) polymorphisms, and measured plasma tHcy. As predicted,COMTVal158carriers had significantly higher tHcy than Met158homozygotes. The effect was limited to individuals homozygous for theMTHFRT677allele. In addition, individuals homozygous for theCOMTG−287allele tended to have lower tHcy levels. High activity variants ofCOMTinteract with the low activity variant ofMTHFRto increase tHcy levels. The effect on tHcy may contribute to the reported associations of COMT genotype with psychiatric and neurobiological phenotypes. The results also indicate that COMT activity may influence a broader range of biochemical pathways than hitherto appreciated.Keywords
This publication has 27 references indexed in Scilit:
- Elevated Prenatal Homocysteine Levels as a Risk Factor for SchizophreniaArchives of General Psychiatry, 2007
- Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE ReviewAmerican Journal of Epidemiology, 2006
- Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson’s disease patientsEuropean Journal of Clinical Pharmacology, 2006
- Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human BrainAmerican Journal of Human Genetics, 2004
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophreniaProceedings of the National Academy of Sciences, 2001
- Effect of L-Dopa and the Catechol-O-Methyltransferase Inhibitor Ro 41–0960 on Sulfur Amino Acid Metabolites in RatsClinical Neuropharmacology, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the EnzymeBiochemistry, 1995